DE CESARIS, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 953
EU - Europa 727
AS - Asia 206
SA - Sud America 3
Totale 1.889
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 950
PL - Polonia 264
IT - Italia 146
IE - Irlanda 123
SE - Svezia 98
HK - Hong Kong 69
CN - Cina 65
CH - Svizzera 45
JO - Giordania 26
SG - Singapore 25
RU - Federazione Russa 20
GB - Regno Unito 12
VN - Vietnam 10
DE - Germania 9
TR - Turchia 5
FI - Finlandia 4
BR - Brasile 3
CA - Canada 3
UA - Ucraina 3
ID - Indonesia 2
IN - India 2
PH - Filippine 2
BY - Bielorussia 1
FR - Francia 1
NL - Olanda 1
Totale 1.889
Salva come PNG Salva come JPEG
Città #
Warsaw 264
Fairfield 142
Dublin 114
Woodbridge 73
Ashburn 71
Chandler 69
Cambridge 60
Seattle 53
Dearborn 50
Altamura 48
Lawrence 47
Houston 46
Bern 45
Hong Kong 44
Wilmington 36
Florence 29
Princeton 26
Beijing 20
Moscow 19
Singapore 19
Boston 17
Medford 17
Shanghai 17
Ann Arbor 14
San Diego 12
Buffalo 11
Kent 11
Milan 10
San Mateo 10
Boardman 8
Dong Ket 8
Fontebuona 6
New York 6
Thiene 5
Andover 4
Hefei 4
Jacksonville 4
Pontassieve 4
Portland 4
Chicago 3
Davis 3
Hillsboro 3
Izmir 3
Laurel 3
London 3
Nanjing 3
Norwalk 3
Toronto 3
Acton 2
Boulder 2
Brescia 2
Bresso 2
Colombo 2
Falls Church 2
Jinan 2
Kunming 2
Mussomeli 2
Naples 2
Phoenix 2
Prato 2
Atlanta 1
Bengaluru 1
Bologna 1
Bremen 1
Calcinaia 1
Dumaguete 1
Ergolding 1
Faenza 1
Fiesole 1
General Santos 1
Guangzhou 1
Hangzhou 1
Hebei 1
Hounslow 1
Kilburn 1
Los Angeles 1
Magdeburg 1
Nanchang 1
Philadelphia 1
Ravenna 1
Redmond 1
Rome 1
Siena 1
São Paulo 1
Trumbull 1
Turin 1
Vinci 1
Wandsworth 1
Washington 1
Totale 1.527
Salva come PNG Salva come JPEG
Nome #
Migraine-provoking substances evoke periorbital allodynia in mice 171
Transient receptor potential channels as novel drug targets in respiratory diseases. 158
Protocol and methods for testing the efficacy of well-being therapy in chronic migraine patients: a randomized controlled trial 146
TRPA1 and other TRP channels in migraine 122
Mental Pain Questionnaire: An item response theory analysis 115
Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura 101
Chronic headaches and medication overuse 99
Post onset, oral rapamycin treatment delays development of mitochondrial encephalopathy only at supramaximal doses 79
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: A post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 79
Acute and chronic triptan exposure neither alters rodent cerebral blood flow nor worsens ischemic brain injury 77
Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study 76
Criterion-related validity in a sample of migraine outpatients: The diagnostic criteria for psychosomatic research 73
Epidemiology and determinants of chronic migraine: A real-world cohort study, with nested case-control analysis, in primary care in Italy 51
Migraine Models 50
Mental pain and pain-proneness in migraine subjects: Results from the PAINMIG cohort-study 48
Ultra-rapid brain uptake of subcutaneous sumatriptan in the rat: Implication for cluster headache treatment 46
Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series 44
Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study From the Italian National Headache Registry (RICe) 40
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score 39
Emerging Pharmacological Treatments for Migraine in the Pediatric Population 36
Predictors of sustained response and effects of the discontinuation of anti-calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraine 36
The role of TRP ion channels in migraine and headache 36
Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study 35
COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report 34
Migraine during covid-19: Data from second wave pandemic in an Italian cohort 30
Mental pain as a global person-centred outcome measure 28
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine 23
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ) 21
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study 19
Switching OnabotulinumtoxinA to Monoclonal Anti-CGRP Antibodies in Drug-Resistant Chronic Migraine 13
Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany 8
Totale 1.933
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.753
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.753
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020434 17 42 7 24 46 76 62 53 40 29 30 8
2020/2021263 19 21 7 23 11 52 10 23 27 36 11 23
2021/2022197 7 6 7 5 7 5 4 14 15 28 38 61
2022/2023576 45 124 39 15 16 81 66 22 55 17 28 68
2023/2024275 7 28 34 25 18 24 19 57 11 14 31 7
2024/202527 27 0 0 0 0 0 0 0 0 0 0 0
Totale 1.933